Time To Revise COPD Treatment Algorithm.

Area of Science:

• Pulmonology
• Internal Medicine
• Pharmacology

Background:

• The 2017 COPD treatment algorithm recommended patient-specialized assessment for specific traits after exacerbations.
• Recent studies highlight the need for earlier intervention with treatments like inhaled corticosteroids (ICS) based on patient characteristics.

Purpose of the Study:

• To propose a revised, 3-step parallel approach for initial COPD treatment.
• To adapt the COPD treatment algorithm for clinical practice by considering patient-specific characteristics and concomitant diseases.

Main Methods:

• Initial COPD diagnosis followed by categorization based on usual COPD characteristics or concomitant diseases.
• Assessment based on dyspnea and exacerbation frequency for usual COPD, or asthma, chronic bronchitis, and heart failure for concomitant diseases.
• Selection of initial therapy including mono-/dual bronchodilators, ICS, roflumilast, macrolides, or selective β1-blockers based on assessment, with a 4-week response review.

Main Results:

• The proposed approach categorizes patients early to guide initial therapy selection.
• It integrates management of concomitant diseases with essential COPD therapy.
• Personalized treatment strategies are recommended based on individual patient profiles.

Conclusions:

• The 3-step parallel approach offers a personalized strategy for initial COPD management.
• Early and individualized assessment of treatable traits is crucial for optimizing COPD treatment.
• This revised algorithm aims to improve clinical practice by tailoring therapy to patient characteristics.